Ozark Health Ventures, LLC dba Cancer Research for the Ozarks (CRO)

Ozark Health Ventures, LLC dba 奥扎克癌症研究 (CRO)

• 批准号: 8927727
• 负责人: Jay W Carlson
• 金额: $ 4.85万
• 依托单位: OZARK HEALTH VENTURES, LLC
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2019-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8927727
• 关键词: Address; Aftercare; Area; Cancer Control; Clinical; Clinical Trials; Clinical Trials Network; Communication; Communities; Community Clinical Oncology Program; Community Networks; Community Outreach; Community Practice; Community Services; Conduct Clinical Trials; Data Quality; Ensure; Family; Funding; Goals; Health; Health Services Accessibility; Healthcare Systems; Hospitals; Illinois; Image; Improve Access; Individual; Leadership; Life; Malignant Neoplasms; Medical; Mentors; Minority; Mission; Missouri; National Cancer Institute; Oncologist; Outcome; Ozarks; Participant; Patients; Physicians; Population; Poverty; Prevention; Principal Investigator; Provider; Research; Research Personnel; Research Support; Resources; Rural Community; Rural Population; Safety; Secure; Services; Site; Woman; anticancer research; base; cancer care; cancer prevention; cancer therapy; care delivery; design; experience; high risk; improved; interest; programs; public health relevance; screening

DESCRIPTION (provided by applicant): For over 26 years, Cancer Research for the Ozarks (CRO) has provided access to NCI-approved clinical trials to the rural communities of southwestern Missouri and surrounding areas through the Community Clinical Program. CRO is eager to transition to an NCI Community Oncology Research Program (NCORP) Community Site and expand access throughout south, central, and eastern Missouri as well as southern Illinois. During the past five years, CRO has added five components expanding to a population that spans central and eastern Missouri, and southern Illinois. Through the visionary leadership of its outstanding Principal Investigators including current Principal Investigator, Jay Carlson, DO, this largely rural population to NCI (NCORP). From its inception, CRO has had the support of the two nationally recognized health care systems, CoxHealth and Mercy Hospital Springfield in Springfield, Missouri providing a unique opportunity to change a wide community of practice. CRO has available access to an extensive network of non-oncology physicians and other medical professionals including geneticists as well as a broad network of community service providers. Based on its experience and expansion, CRO is confident it can secure over 200 accruals and credits per year in cancer treatment, prevention, and control. CRO is enthusiastic about the realignment of scope in research trials including expanded plans for cancer prevention and control. CRO fully supports new NCORP priorities to address cancer care delivery and disparities are consistent with ongoing efforts to improve access, service delivery, and outcomes at all CRO components.

描述（由申请人提供）：26年来，Ozarks癌症研究（CRO）通过社区临床计划为密苏里州西南部及周边地区的农村社区提供了获得NCI批准的临床试验的机会。CRO渴望过渡到NCI社区肿瘤学研究计划（NCORP）社区站点，并在整个密苏里州南部、中部和东部以及伊利诺伊州南部扩大访问范围。 在过去的五年里，CRO增加了五个组成部分，扩大到人口跨越中部和东部密苏里州，以及伊利诺伊州南部。通过其杰出的主要研究者（包括现任主要研究者Jay Carlson，DO）的富有远见的领导，这个主要是农村人口的国家癌症研究所（NCORP）。 从一开始，CRO就得到了两个国家认可的医疗保健系统的支持，即位于密苏里州斯普林菲尔德的CoxHealth和Mercy Hospital Springfield，为改变广泛的实践社区提供了独特的机会。CRO可以接触到广泛的非肿瘤医生和其他医疗专业人员（包括遗传学家）网络以及广泛的社区服务提供者网络。 基于其经验和扩张，CRO有信心每年在癌症治疗、预防和控制方面获得200多笔应计利润和信贷。CRO热衷于研究试验范围的重新调整，包括癌症预防和控制的扩展计划。CRO完全支持新的NCORP优先事项，以解决癌症护理提供和差异是一致的，以改善所有CRO组件的访问，服务提供和结果的持续努力。